SenesTech, Inc. (SNES)
| Market Cap | 9.31M |
| Revenue (ttm) | 249,000 |
| Net Income (ttm) | -9.07M |
| Shares Out | 3.40M |
| EPS (ttm) | -3.95 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | January 20 |
| Last Price | $2.17 |
| Previous Close | $2.13 |
| Change ($) | 0.04 |
| Change (%) | 1.88% |
| Day's Open | 2.38 |
| Day's Range | 2.13 - 2.39 |
| Day's Volume | 1,086,945 |
| 52-Week Range | 1.36 - 11.54 |
SenesTech, Inc. (SNES) CEO Ken Siegel on Q3 2020 Results - Earnings Call Transcript
PHOENIX, Nov. 11, 2020 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary, next generation technologies for managing animal pest populations through fertility control, ...
PHOENIX, Nov. 11, 2020 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, today announced t...
PHOENIX, Nov. 4, 2020 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, will report financ...
PHOENIX, Sept. 24, 2020 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, is scheduled to ...
Wall Street recommends to buy shares of SenesTech Inc (NASDAQ:SNES) and Delcath Systems Inc (NASDAQ:DCTH), even though these two stocks have disappointed so much over the prior 52 weeks throug...
SenesTech, Inc. (SNES) CEO Kenneth Siegel on Q2 2020 Results - Earnings Call Transcript
PHOENIX, Aug. 12, 2020 /PRNewswire/ -- SenesTech, Inc.
PHOENIX, June 11, 2020 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, encourages busine...
SenesTech's (SNES) CEO Ken Siegel on Q1 2020 Results - Earnings Call Transcript
SenesTech's (SNES) CEO Ken Siegel on Q3 2019 Results - Earnings Call Transcript
SenesTech, Inc. (SNES) CEO Ken Siegel on Q2 2019 Results - Earnings Call Transcript
On Tuesday, August 13, SenesTech (NASDAQ: SNES) will release its latest earnings report.
Price dropped to a cheaper level of stock offering, not due to any new numbers reporting.
CEO of Senestech Inc (30-Year Financial, Insider Trades) Kenneth S Siegel (insider trades) bought 696,296 shares of SNES on 07/16/2019 at an average price of $1.35 a share.
SNES produces an innovative rodent pest control that tackles major challenges of rodenticides.
SenesTech, Inc. (SNES) CEO Ken Siegel on Q1 2019 Results - Earnings Call Transcript
Senestech, Inc. (SNES) CEO Loretta Mayer on Q4 2018 Results - Earnings Call Transcript
About SNES
SenesTech develops a technology for managing animal pest populations through fertility control. The company offers ContraPest, a liquid bait that targets reproduction, and limiting fertility in male and female rats for controlling rat populations. It is also developing a pipeline of fertility control and animal health products, including feral animal fertility control, non-surgical spay and neutering, boar taint, and animal cancer treatment. The company was founded in 2004 and is headquartered in Phoenix, Arizona.
| Industry Specialty Chemicals | IPO Date Dec 8, 2016 |
| CEO Kenneth Siegel | Employees 34 |
| Stock Exchange NASDAQ | Ticker Symbol SNES |
Financial Performance
In 2019, SenesTech's revenue was $143,000, a decrease of -51.85% compared to the previous year's $297,000. Losses were -$10.02 million, -15.87% less than in 2018.
Analyst Forecasts
The average 12-month stock price forecast for SenesTech is 4.00, which is an increase of 84.33% from the latest price.